General Information of the Compound
Compound ID
CP0398176
Compound Name
N-[2-[4-(1,2-benzoxazol-3-yl)piperazin-1-yl]ethyl]-4-fluorobenzamide
    Show/Hide
Structure
Formula
C20H21FN4O2
Molecular Weight
368.412
Canonical SMILES
Fc1ccc(cc1)C(=O)NCCN1CCN(CC1)c1noc2ccccc12
    Show/Hide
InChI
InChI=1S/C20H21FN4O2/c21-16-7-5-15(6-8-16)20(26)22-9-10-24-11-13-25(14-12-24)19-17-3-1-2-4-18(17)27-23-19/h1-8H,9-14H2,(H,22,26)
    Show/Hide
InChIKey
ISOUPXKKYOUPJK-UHFFFAOYSA-N
Physicochemical Property
logP
2.5189
Rotatable Bonds
5
Heavy Atom Count
27
Polar Areas
61.61
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 49788939
SID: 103064024
ChEMBL ID
CHEMBL1270323
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02684, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 0.34 nM
   TI
   LI
   LO
   TS